Abstract
Silica-based nanoparticles have recently raised a great deal of attention as possible drug carriers. Such an interest is driven by the possibility to control their size, the chemical composition and the porous structure as well as to easily modify their surface with a wide range of biologically-relevant functionalities, favoring colloidal stability, long-time blood circulation and even specific targeting. Drug loading can be performed during particle formation but, at this time, the most popular method relies on the impregnation of pre-formed mesoporous colloids. Strategies to control drug delivery via bio-responsive pore capping are also developed. However, despite an increasing number of in vitro and in vivo studies related to the interaction of silica particles with cells and animals, their biocompatibility is still an issue, especially if applications in intracellular drug delivery are foreseen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- FITC:
-
fluorescein isothiocyanate
- HSN:
-
hollow silica nanoparticles
- MSN:
-
mesoporous silica nanoparticles
- PEG:
-
polyethylene glycol
- PEI:
-
polyethylene imine
- PLGA:
-
poly(lactic-co-glycolic acid)
- PLLA:
-
poly-L-lactic acid
- PVP:
-
polyvinylpyrrolidone
- RES:
-
reticuloendothelial system
- siRNA:
-
short-interfering RNA
- TEOS:
-
tetraethoxysilane
References
Akhtar MJ, Ahmed M, Kumar S, Siddiqui H, Patil G, Ashquin M, Ahmad I (2010) Nanotoxicity of pure silica mediated through oxidant generation rather than glutathionne depletion in human lung epithelial cells. Toxicol 276:95–102
Allouche J, Boissière M, Hélary C, Livage J, Coradin T (2006) Biomimetic core-shell gelatine/silica nanoparticles: a new example of biopolymer-based nanocomposites. J Mater Chem 16: 3121–3126
Andersson N, Alberius PCA, Pedersen JS, Bergstrom L (2004)Structural features and adsorption behaviour of mesoporous silica particles formed from droplets generated in a spraying chamber. Microporous Mesoporous Mater 72:175–183
Arcangeli G, Rotella CM, Giuliano G, Arcangeli P (1990) Induction of cell from patients with silicosis by silica crystals. Effects of cell-derived factors and silica particles on human lung fibroblasts proliferation and biosynthesis. Int J Immunopathol Pharmacol 3:51–61
Arriagada FJ, Osseo-Asare K (1995) Synthesis of nanosize silica in a nonionic water-in-oil microemulsion: effects of the water/surfactant molar ratio and ammonia concentration. J Colloid Interf Sci 211:210–220
Baccile N, Grosso D, Sanchez C (2003) Aerosol generated mesoporous silica particles. J Mater Chem 13:3011–3016
Bagchi N (1992) What makes silica toxic ? Br J Ind Med 49:163–166
Balas F, Manzano M, Horcajada P, Vallet-Regi M (2006) Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials, J Am Chem Soc 128:8116–8117
Barbé C, Bartlett J, Kong L, Finni K, Lin HQ, Larkin M, Calleja S, Bush A, Calleja G (2004) Silica particles: a novel drug-delivery system. Adv Mater 16:1959–1966
Barnes CA, Elsaesser A, Arkusz J et al (2008) Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett 8:3069–3074
Bass JD, Grosso D, Boissière C, Coradin T, Sanchez C (2007) The stability of mesoporous oxide and mixed-metal oxide materials under biologically-relevant conditions. Chem Mater 19: 4349–4354
Bharali DJ, Klejbor I, Stachowiak EK, Dutta P, Roy I, Kaur N, Bergey EJ, Prasad PN, Stachowiak MK (2005) Organically modified silica nanoparticles: A nonviral vector for in-vivo gene delivery and expression in the brain, Proc Natl Acad Sci USA 102:11539–11544
Bégu S, Aubert Pouëssel Lerner DA, Charnay C, Tourné-Péteilh C, Devoisselle JM (2007) Liposil, a promising composite material for drug storage and release. J Controlled Release 118:1–6
Bogush GH, Tracy MA, Zukoski IV CF (1988) Preparation of monodisperse silica particles: control of size and mass fraction. J Non-Cryst Solids 104:95–106
Boissiere C, Grosso D, Chumonnot A, Nicole L, Sanchez C (2010) Aerosol route to functional nanostructured inorganic and hybrid porous materials. Adv Mater DOI: 10.1002/adma.201001410
Boissière M, Meadows PJ, Brayner R, Hélary C, Livage J, Coradin T (2006) Turning biopolymer particles into hybrid capsules: the example of silica/alginate nanocomposites. J Mater Chem 16:1178–1182
Breunig M, Bauer S, Goepferich A (2008) Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur J Pharm Biopharm 68:112–128
Brinker CJ, Lu Y, Sellinger A, Fan H (1999) Evaporation-Induced Self-Assembly: nanostructures made easy. Adv Mater 11:579–585
Bruchez M, Moronne M, Gin P, Weiss S, Alivisatos AP (1998) Semiconductor nanocrystals as fluorescent biological labels, Science 281:2013–2016
Burns AA, Vider J, Ow H et al (2009) Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 9:442–448
Caruso F, Caruso RA, Möhwald H (1998) Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating, Science 282:1111–1114
Cauda V, Argyo C, Bein T (2010) Impact of different PEGylation patterns on the long-term bio-stability of colloidal mesoporous silica nanoparticles. J Mater Chem 20:8693–8699
Chang JS, Chang KLB, Hwang DF, Kong ZL (2007) In vitro cytotoxicity of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ Sci Technol 41:2064–2068
Chang, SM, Lee M, Kim WS (2005) Preparation of large monodispersed spherical silica particles using seed particle growth. J Colloid Interf Sci 286:536–542
Chen JF, Ding HM, Wang JX, Shao L (2004) Preparation and characterization of porous hollow silica nanoparticles for drug delivery application, Biomaterials 25:723–727
Choi J, Zheng Q, Katz HE, Guilarte TR (2010) Silica-based nanoparticle uptake and cellular response by primary microglia. Env Health Persp 118:589–595
De Monredon-Senani S, Bonhomme C, Ribot F, Babonneau F (2009) Covalent grafting of organoalkoxysilanes on silica surfaces in water-rich medium as evidenced by 29Si NMR. J Sol-Gel Sci Technol 50:152–157
Deng G, Markowitz MA, Kust PR, Gaber BP (2000) Control of surface expression of functional groups on silica particles, Mater Sci Eng C 11:165–172
Depasse J (1977) Comparison between two hypotheses about the physicochemical basis of the toxicity of silica. J Colloid Interf Sci 60:414–415
Di Pasqua AJ, Sharma KK, Shi YL, Toms BB, Ouellette W, Dabrowiak JC, Asefa T (2008) Cytotoxicity of mesoporous silica nanomaterials. J Inorg Biochem 102:1416–1423
Doadrio JC, Sousa EMB, Izquierdo-Barba I, Doadrio AL, Perez-Pariente J, Vallet-Regi M (2006) Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern, J Mater Chem 16:462–466
Erdogu G, Hasirci V (1998) An overview of the role of mineral solubility in silicosis and abestosis. Environ Res Sect A 78:38–42
Fent K, Weisbrod CJ, Wirth-Heller A, Pieles U (2010) Assessment of uptake and toxicity of fluorescent silica nanoparticles in zebrafish (Danio rerio) early life stages. Aquatic Toxicol 100:218–228
Finnie KS, Jacques DA, McGann MJ, Blackford MG, Barbé CJ (2006) Encapsulation and controlled release of biomolecules from silica microparticles. J Mater Chem 16:4494–4498.
Finnie KS, Waller DJ, Perret FL, Krause-Heuer AM, Lin HQ, Hanna JV, Barbé CJ (2009) Biodegradability of sol-gel silica microparticles for drug delivery. J Sol-Gel Sci Technol 49:12–18
Fuller J, Zugates G, Ferreira L, Ow H, Nguyen N, Wiesner U, Langer R (2008) Intracellular delivery of core-shell fluorescent silica nanoparticles. Biomaterials 29:1526–1532
Galagudza MM, Korolev DV, Sonin DL, Postnov VN, Papayan GV, Uskov IS, Belozertseva AV, Shlyakhto EV (2010) Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface, functionalization, natural biodistribution and acute toxicity. Int J Nanomed 5:231–237
Gan LM, Zhang K, Chew CH (1996) Preparation of silica nanoparticles from sodium orthosilicate in inverse microemulsions. Colloid Surf A 110:199–206
Giljohann DA, Seferos DS, Prigodich AE, Patel PC, Mirkin CA (2009) Gene regulation with polyvalent siRNA-nanoparticle conjugates, J Am Chem Soc 131:2072–2073
Gong C, Tao G, Yang L, Liu J, Liu Q, Zhuang Z (2010) SiO2 nanoparticles induce global genomic hypomethylation in HaCaT cells. Biochem Biophy Res Commun 397:397–400
He Q, Zhan J, Shi J, Zhu Z, Zhang L, Bu W, Guo L, Chen Y (2010) The effect of PEGylation of mesoporous silica nanoparticles on the binding of serum proteins and cellular responses. Biomaterials 31:1085–1092
Higashisaka K, Yoshioka Y, Yamashita K et al. (2011) Acute phase proteins as biomarkers for predicting the exposure and toxicity of nanomaterials. Biomaterials 32:3–9
Hu L, Mao Z, Gao C (2009) Colloidal particles for cellular uptake and delivery. J. Mater. Chem. 19:3108–3115
Huang DM, Hung Y, Ko BS et al. (2005) Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. FASEB J 19:2014–2016
Huang X, Teng X, Chen D, Tang F, He J (2010) The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 31:438–448
Hudson SP, Padera RF, Langer R, Kohane DS (2008) The biocompatibility of mesoporous silicates. Biomaterials 29:4045–4055
Icopini GA, Brantley SL, Heaney PJ (2005) Kinetics of silica oligomerization and nanocolloid formation as a function of pH and ionic strength at 25°C. Geochim Cosmochim Acta 69:293–303
Iler RK (1979), The Chemistry of Silica, Wiley, New York
Iskandar F, Gradon L, Okuyama K (2003) Control of the morphology of nanostructured particles prepared by the spray drying of a nanoparticle sol. J Colloid Interf Sci 265:296–303
Izquierdo-Barba I, Colilla M, Manzano M, Vallet-Regi M (2010) In vitro stability of SBA-15 under physiological conditions. Microporous Mesoporous Mater 132:442–452
Jin YH, Li AZ, Hazelton SG, Liang S, John CL, Selid PD, Pierce DT, Zhao JX (2009) Amorphous silica nanohybrids: synthesis, properties and applications, Coord Chem Rev 253:2998–3014
Jung CY, Kim JS, Chang TS, Kim ST, Lim HJ, Koo SM (2010) One step synthesis of structurally-controlled silicate particles from sodium silicate particles from sodium silicates using a simple precipitation process. Langmuir 26:5456–5461
Kumar R, Roy I, Ohulchanskky TY, Vathy LA, Bergey EJ, Sajjad M, Prasad PN (2010) In vivo biodistribution and clearance studies using multimodal organically-modified silica nanoparticles. ACS Nano 4:699–708
Kim H., Kim S., Park C., Lee H., Park HJ, Kim C (2010) Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers. Adv Mater 22:4280–4283
Kim S, Ohulchanskyy TY, Pudavar HE, Pandey RK, Prasad PN (2007) Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodymamic therapy, J Am Chem Soc 129:2669–2675
Lai CY, Trewyn BG, Jeftinija DM, Jeftinija K, Xu S, Jeftinija S, Lin VSY (2003) A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimumi-responsive controlled released of neurotransmitters and drug molecules, J Am Chem Soc 125:4451–4459
Li Z, Wen L, Shao L, Chen J (2004) Fabrication of porous hollow silica nanoparticles and their applications in drug release control, J. Control Release 98:245–254
Lin W, Huang Y, Zhou XD, Ma Y (2006) In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharm 21:252–259
Lin YS, Haynes CL (2010) Impacts of mesoporous silica nanoparticle size, pore ordering and pore integrity on hemolytic activity. J Am Chem Soc 132:4834–4842
Linthicum DS (2001) Untrastructural effects of silicic acid on primary lung fibroblasts in tissue culture. Tissue Cell 33:514–523
Liu X, Sun J (2010) Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kB pathways. Biomaterials 31:8198–8209
Liu Y, Miyoshi H, Nakamura M (2007a) Nanomedicine for drug delivery and imaging : A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticle, Int J Cancer 120:2527–2537
Liu Y, Miyoshi H, Nakamura M (2007b) Novel drug delivery system of hollow mesoporous silica capsules with thin shells: Preparation and fluorescein isothiocyanate (FITC) release kinetics, Colloids Surf B 58:180–187
Lord MS, Cousins BG, Doherty PJ, Whitelock JM, Simmons A, Williams RL, Milthorpe BK (2006) The effect of silica nanoparticulate coatings on serum protein adsorption and cellular response. Biomaterials 27:4856–4862
Lu F, Wu SH, Hung Y, Mou CY (2009) Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5:1408–1413
Lu J, Liong M, Fink ZI, F. Tamanoi F (2007) Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drug, Small 3:1341–1346
Lu J, Liong M, Li Z, Zink J, Tamanoi F (2010) Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small. 6:1794–1805
Mailaender V, Landfester K (2009) Interaction of Nanoparticles with Cells. Biomacromolecules 10:2379–2400
Mao Z, Wan L, Hu L, Ma L, Gao C (2010) Tat peptide mediated cellular uptake of SiO2 submicron particles. Colloids Surf B 75:432–440
Mellaerts R, Mols R, Jammaer JAG, Aerts CA, Annaert P, Humbeeck JV, Van den Mooter G, Augustijns P, Martens JA (2008) Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica, Eur J Pharm Biopharm 69:223–230
Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K (2009) Histological analysis of 70 nm silica particles-induced chronic toxicity in mice. Eur J Pharm Biopharm 72:626–629
Park YH, Kim JN, Jepong SH et al (2010) Assessment of dermal toxicity of nanosilica using culture keratinocytes, a human skin equivalent model and an in vivo model. Toxicol 267:178–181
Radhakrishnan B, Ranjan R, Brittain WJ (2006) Surface initiated polymerizations from silica nanoparticles. Soft Matter 2:386–396
Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VSY (2004) A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent, J Am Chem Soc 126:13216–13217
Rao KS, El-Hami K, Kodaki T, Matsushige K (2005) A novel method for the synthesis of silica nanoparticles. J Colloid Interf Sci 289:125–131
Rimer JD, Trofymluk O, Navrotsky A, Lobo RF, Vlachos DG (2007) Kinetic and thermodynamic studies of silica nanoparticle dissolution. Chem Mater 19:4189–4197
Rosenholm J, Meinander A, Peuhu E, Niemi R, Eriksson J, Sahlgren C, Lindén M (2009) Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 3:197–206
Rosenholm JM, Sahlgren C, Linden M (2010) Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles- opportunities & challenges. Nanoscale 2:1870–1883
Santra S (2004) TAT conjugated, FITC doped silica nanoparticles for bioimaging applications, Chem Commun 24:2810–2811
Sauer A, Schlossbauer A, Ruthardt N, Cauda V, Bein T, Bräuchle C (2010) Role of Endosomal Escape for Disulfide-Based Drug Delivery from Colloidal Mesoporous Silica Evaluated by Live-Cell Imaging. Nano Lett 10:3684–3691
Sertchook H, Elimelech H, Makarov C, Khalfin R, Cohen Y, Shuster M, Babonneau F, Avnir D (2007) Composite particles of polyethylene@silica. J Am Chem Soc 129:98–108.
Sola R, Boj M, Hernandez-Felix S, Camprubi M (2009) Silica in oral drugs as a possible sarcoidosis-inducing antigen. Lancet 373:1943–1944
Slowing II, Trewyn BG, Lin VSY (2006) Effect of surface functionalisation of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc 128:14792–14793
Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60: 1278–1288
Soler Illia GJ, Sanchez C, Lebeau B, Patarin J (2002) Chemical strategies to design textured materials: from microporous and mesoporous oxides to nanonetworks and hierarchical structures. Chem Rev 102:4093–4138
Souris JS, Lee CH, Cheng SH, Chen CT, Yang CS, Ho JA, Mou CY, Lo LW (2010) Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials 31:5564–5574
Stöber W, Fink A, Bohn E (1968) Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interf Sci 26:62–69
Tao Z, Toms BB, Goddisman J, Asefa T (2009) Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials. Chem Res Toxicol 22:1869–1880
Taylor-Pashow KML, Rocca JD, Huxford R, Lin W (2010) Hybrid nanomaterials for biomedical applications, Chem Commun 46:5832–5849
Thierry B, Zimmer L, McNiven S, Finnie K, Barbé C, Griesser HJ (2008) Electrostatic self-assembly of PEG copolymers onto porous silica nanoparticles, Langmuir 24:8143–8150
Trewyn BG, Nieweg JA, Zhao Y, Lin VSY (2008) Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration. Chem Engin J 137:23–29
Vallhov H, Gabrielsson S, Stromme M, Scheynius A, Garcia-Bennett AE (2007) Mesoporous silica particles induce size dependent effects on human dendritic cells. Nano Lett 7: 3576–3582
Vallet-Regi M (2006) Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering, Chem Eur J 12:5934–5943
Van Shooneveld MM, Vucic E, Koole R, Zhou Y, Stocks J, Cormode DP, Tang CY, Gordon RE, Nicolay K, Meijerink A, Fayad ZA, Mulder WJM (2008) Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett 8:2517–2525
Vivero-Escoto JL, Slowing II, Lin VSY (2010a) Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa. Biomaterials 31:1325–1333
Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VSY (2010b) Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery. Small 6:1952–1967
Vogelsberger W, Seidel A, Rudakoff G (1992) The solubility of silica in water. J Chem Soc Faraday Trans 88:473–476
Wallace AF, Gibbs, GV, Dove PM (2010) Influence of ion-associated water on the hydrolysis of Si-O bonded interactions. J Phys Chem A 114:2534–2542
Wang F, Gao F, Lan M, Yuan H, Huang Y, Liu J (2009) Oxidative stress contributes to silica nanoparticle-induces cytotoxicity in human embryonic kidney cells. Toxicol in Vitro 23:808–815
Wang L, Wang K, Santra S, Zhao X, Hilliard LR, Smith JE, Wu Y, Tan W (2006) Watching silica nanoparticles glow in the biological world, Anal Chem 78:646–654
Wang L, Zhao W, Tan W (2008) Bioconjugated silica nanoparticles, Nano Res 1:99–115
Xie G, Sun J, Zhong G, Shi L, Zhang D (2010) Biodistribution and toxicity of intravenously administered silica nanoparticles in mice. Arch Toxicol 84:183–190
Yang H, Liu C, Yang D, Zhang H, Xi Z (2009) Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol 29:69–78
Yang J, Lee J, Kang J, Lee K, Suh J, Yoon Y, Haam S (2008) Hollow silica nanocontainers as drug delivery vehicles, Langmuir 24:3417–3421
Yang Y, Coradin T (2008) A green route to silica nanoparticles with controlled size and structure. Green Chem 10:183–190
Ye Y, Liu J, Sun L, Chen M, Lan M (2010) Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. Toxicol in Vitro 24:751–758
Yezhelyev MV, Qi L, O’Regan RM, Nie S, Gao X (2008) Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging, J Am Chem Soc 130:9006–9012
Zalzberg L, Avnir D (2008) Biocompatible hybrid particles of poly(L-lactic acid)@silica. J Sol-Gel Sci Technol 48:47–50
Zhang Y, Hu L, Yu D, Gao C (2010) Influence of silica particle internalization on adhesion and migration of human dermal fibroblasts. Biomaterials 31:8465–8474
Zou H, Wu S, Shen J (2008) Preparation of silica-coated poly(styrene-co-4-vinylpyridine) particles and hollow particles. Langmuir 24:10453–10461
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Quignard, S., Masse, S., Coradin, T. (2011). Silica-Based Nanoparticles for Intracellular Drug Delivery. In: Prokop, A. (eds) Intracellular Delivery. Fundamental Biomedical Technologies, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1248-5_12
Download citation
DOI: https://doi.org/10.1007/978-94-007-1248-5_12
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-1247-8
Online ISBN: 978-94-007-1248-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)